Trials / Unknown
UnknownNCT02790190
Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase III Study of Individualized Adaptive Radiotherapy Based on PET/CT and 3DCRT/IMRT in Combination With Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Shandong Cancer Hospital and Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a perspective, multicenter,randomized controlled trial to compare the efficacy and safety of radiotherapy Based on PET/CT and IMRT combined with concurrent chemotherapy in patients with locally advanced non small cell lung cancer . Analyses of overall survival (OS) will be done as defined in the protocol.
Detailed description
https://register.clinicaltrials.gov/prs/app/template/Home.vm?uid=U000184Z\&ts=76\&sid=S0006AP2\&cx=r0ratc
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Radiotherapy dose |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-06-03
- Last updated
- 2016-06-03
Locations
24 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02790190. Inclusion in this directory is not an endorsement.